Sunshine Heart Inc  

(Public, ASX:SHC)   Watch this stock  
Find more results for SHC
0.0000
- Close
ASX data delayed by 20 mins - Disclaimer
Currency in
Range     -
52 week 0.02 - 0.06
Open     -
Vol. 0.00
Mkt cap     -
P/E     -
Div/yield     -
EPS -1.81
Shares     -
Beta     -
Inst. own     -

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin -10732.20% -36877.96%
Operating margin -10788.14% -38764.41%
EBITD margin - -38450.85%
Return on average assets -48.79% -61.93%
Return on average equity -51.87% -67.28%
Employees 36 -
CDP Score - -

Address

7651 ANAGRAM DRIVE
EDEN PRAIRIE, MN 55344
United States - Map
+1-952-3454200 (Phone)
+1-302-6365454 (Fax)

Website links

Description

Sunshine Heart, Inc. is an early-stage medical device company focused on developing, manufacturing and commercializing its C-Pulse Heart Assist System for treatment of Class III and ambulatory Class IV heart failure. The C-Pulse Heart Assist System utilizes the scientific principles of intra-aortic balloon counter-pulsation applied in an extra-aortic approach to assist the left ventricle by reducing the workload required to pump blood throughout the body, while increasing blood flow to the coronary arteries. As of December 31, 2011, the Company was in the process of obtaining regulatory approvals necessary to sell its product. During the year ended December 31, 2011, the Company completed enrollment and implantation of 20 patients in the North American feasibility phase of its trial. In April 2011, the Food and Drug Administration (FDA) approved an expansion protocol to allow the Company to implant up to 20 additional patients and add two additional centers to its feasibility study.

Officers and directors

John L. Erb Independent Chairman of the Board
Age: 64
David A. Rosa Chief Executive Officer, Director
Age: 49
Jeffrey S. Mathiesen Chief Financial Officer, Secretary
Age: 52
Debra J. Kridner Executive Vice President - Clinical Research & Regulatory Affairs
Age: 61
Brian Brown Senior Vice President - Operations and Technology
Kimberly Oleson Senior Vice President - Clinical Affairs
William S. Peters M.D. Chief Technical Officer, Medical Director
Age: 47
James Yearick Vice President - Marketing & Sales
Age: 50
Patrick Verta M.D. Chief Medical Officer
Geoffrey E.D. Brooke Independent Director